Articles by Chad Landmon - BioPharm International

ADVERTISEMENT

ADVERTISEMENT

Articles by Chad Landmon

Advocating for Biosimilar Approval Standards Under BPCI

FDA weighs multiple views regarding the Biologics Price Competition and Innovation Act.
Sep 1, 2011

FDA weighs multiple views regarding the Biologics Price Competition and Innovation Act.

ADVERTISEMENT

ADVERTISEMENT

Click here